Data protection Impressum

Life sciences

Inaugurated in May 2025, the PULSE Innovation Center in Cheseaux-sur-Lausanne is emerging as a flagship site for life sciences and high-tech companies in Western Switzerland, offering modular infrastructure, shared services, and a unique environment for collaboration and growth.

PULSE, a new era for innovation in Western Switzerland

21 May 2025

Swiss Medical Network has become the first healthcare provider in Western Europe to join the prestigious Mayo Clinic Care Network. The collaboration strengthens Switzerland’s position as a hub for advanced medical innovation and international clinical partnerships.

Swiss Medical Network joins Mayo Clinic Care Network to elevate patient care

13 May 2025

Neuchâtel’s CSEM is playing a central role in the QUESTIONED project, an initiative aiming to reduce postoperative delirium (POD) in elderly patients through real-time brain activity monitoring during anesthesia.

CSEM technology supports breakthrough in EEG monitoring to reduce postoperative delirium

12 May 2025

HAYA Therapeutics, a precision medicine company based at Biopôle in Lausanne, has closed a USD 65 million Series A funding round to accelerate the clinical development of its RNA-guided therapies and expand its regulatory genome platform.

HAYA Therapeutics raises USD 65 million to advance RNA-guided therapies for chronic disease

12 May 2025

The latest edition of the Swiss Biotech Report underscores the continued growth and resilience of Switzerland’s biotech sector, attributing success to strong international collaborations and innovative advancements that promise to reshape healthcare worldwide.

The Swiss biotech industry: building resilience through global alliances

6 May 2025

University of Bern researchers develop ultrasound-powered method to clean stents non-invasively, improving patient care and reducing hospital costs.

University of Bern researchers pioneer ultrasound-based method to clean implanted medical devices

5 May 2025

Burgdorf-based medtech Ypsomed has announced the sale of its diabetes care business to TecMed AG for up to CHF 420 million. The move marks a significant strategic shift, positioning Ypsomed as a pure-play provider of self-injection systems for pharmaceutical and biotech partners worldwide.

Bern-based Ypsomed pivots with CHF 420 million diabetes unit sale to TecMed

23 April 2025

A collaborative research team from EPFL, the University of Geneva (UNIGE), and Geneva University Hospitals (HUG) has been awarded the 2025 Leenaards Science Prize for a pioneering project aimed at enhancing the effectiveness of immunotherapy by altering the mechanical properties of cancer cells.

Western Switzerland research teams explore new strategy to boost cancer immunotherapy

14 April 2025

Medtech start-up Novigenix has received EUR 1.8 million from the EU’s Innovative Health Initiative to support the industrialization of its AI-driven liquid biopsy platform as part of a major international cancer research collaboration.

Novigenix secures EUR 1.8 million to scale precision oncology platform

9 April 2025

The CHUV has officially inaugurated its new Children’s Hospital in Lausanne, consolidating pediatric care and setting a new standard for child-centered healthcare infrastructure in Western Switzerland.

CHUV’s new Children’s Hospital enhances pediatric care in Western Switzerland

8 April 2025

1 2 3 4 5 6 … 42